| Buvidal 24 mg Prolonged-release solution for injection EU/1/18/1336/003 |
Buprenorphine |
Camurus AB |
— |
| Buvidal 32 mg Prolonged-release solution for injection EU/1/18/1336/004 |
Buprenorphine |
Camurus AB |
— |
| Buvidal 64 mg Prolonged-release solution for injection EU/1/18/1336/005 |
Buprenorphine |
Camurus AB |
— |
| Buvidal 8 mg Prolonged-release solution for injection EU/1/18/1336/001 |
Buprenorphine |
Camurus AB |
— |
| Buvidal 96 mg Prolonged-release solution for injection EU/1/18/1336/006 |
Buprenorphine |
Camurus AB |
— |
| BYANNLI 1 000 mg prolonged-release suspension for injection in pre-filled syringe EU/1/20/1453/008 |
Paliperidone palmitate |
Janssen-Cilag International NV |
— |
| BYANNLI 700 mg prolonged-release suspension for injection in pre-filled syringe EU/1/20/1453/007 |
Paliperidone palmitate |
Janssen-Cilag International NV |
— |
| Bydureon 2 mg powder and solvent for prolonged-release suspension for injection EU/1/11/696/001-004 |
Exenatide |
AstraZeneca AB |
— |
| Bydureon 2 mg prolonged-release suspension for injection in pre-filled pen EU/1/11/696/005-006 |
Exenatide |
AstraZeneca AB |
— |
| BYETTA 10 micrograms Solution for injection EU/1/06/362/3-4 |
Exenatide |
AstraZeneca AB |
— |
| BYETTA 5 micrograms Solution for injection EU/1/06/362/1-2 |
Exenatide |
AstraZeneca AB |
— |
| Byfavo 20 mg powder for solution for injection EU/1/20/1505/001 |
Remimazolam besilate, Remimazolam (in house) |
Paion Pharma GmbH |
— |
| Byfavo 50 mg powder for concentrate for solution for injection/infusion EU/1/20/1505/002 |
Remimazolam besilate |
Paion Pharma GmbH |
— |
| Bylvay 1 200 micrograms hard capsules EU/1/21/1566/004 |
Odevixibat sesquihydrate |
Ipsen Pharma |
— |
| Bylvay 200 micrograms hard capsules EU/1/21/1566/001 |
Odevixibat sesquihydrate |
Ipsen Pharma |
— |
| Bylvay 400 micrograms hard capsules EU/1/21/1566/002 |
Odevixibat sesquihydrate |
Ipsen Pharma |
— |
| Bylvay 600 micrograms hard capsules EU/1/21/1566/003 |
Odevixibat sesquihydrate |
Ipsen Pharma |
— |
| Byooviz 10 mg/ml solution for injection EU/1/21/1572/001 |
Ranibizumab |
Samsung Bioepis NL B.V. |
— |
| Cabazitaxel Accord 20 mg/ml concentrate for solution for infusion EU/1/20/1448/001 |
Cabazitaxel |
Accord Healthcare S.L.U. |
— |
| Cabazitaxel Fresenius Kabi 20 mg/ml concentrate for solution for infusion PA2059/082/001 |
Cabazitaxel |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Cabazitaxel MSN 60 mg concentrate and solvent for solution for infusion PA23250/002/001 |
Cabazitaxel |
MSN Labs Europe Limited |
Not marketed |
| Cabergoline 1 mg Tablets PA22865/011/001 |
Cabergoline |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Cabergoline 2 mg Tablets PA22865/011/002 |
Cabergoline |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Cabergoline 500 micrograms Tablets PA22865/014/001 |
Cabergoline |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Cablivi 10 mg Powder and solvent for solution for injection EU/1/18/1305/001 |
caplacizumab |
Ablynx |
— |
| CABOMETYX 20 mg film-coated tablets EU/1/16/1136/001-002 |
Cabozantinib |
Ipsen Pharma |
— |
| CABOMETYX 40 mg film-coated tablets EU/1/16/1136/003-004 |
Cabozantinib |
Ipsen Pharma |
— |
| CABOMETYX 60 mg film-coated tablets EU/1/16/1136/005-006 |
Cabozantinib |
Ipsen Pharma |
— |
| Caelyx pegylated liposomal 2 mg/ml concentrate for solution for infusion EU/1/96/011/001-004 |
DOXORUBICIN HYDROCHLORIDE |
Baxter Holding B.V. |
— |
| Calquence 100 mg hard capsules EU/1/20/1479/001-002 |
Acalabrutinib |
AstraZeneca AB |
— |
| Calquence film-coated tablets EU/1/20/1479/001-004 |
Acalabrutinib maleate |
AstraZeneca AB |
— |
| Calrecia 100 mmol/l, solution for infusion PA1350/006/001 |
Calcium chloride dihydrate |
Fresenius Medical Care Deutschland GmbH |
Marketed |
| CAMCEVI 42 mg prolonged-release suspension for injection EU/1/22/1647/001 |
Leuprorelin Mesilate, Leuprorelin |
Accord Healthcare S.L.U. |
— |
| Camzyos 10 mg Capsule hard EU/1/23/1716/005-006/011 |
Mavacamten |
Bristol-Myers Squibb Pharma EEIG |
— |
| Camzyos 15 mg Capsule hard EU/1/23/1716/007-008/012 |
Mavacamten |
Bristol-Myers Squibb Pharma EEIG |
— |
| Camzyos 2.5 mg Capsule hard EU/1/23/1716/001-002/009 |
Mavacamten |
Bristol-Myers Squibb Pharma EEIG |
— |
| Camzyos 5 mg Capsule hard EU/1/23/1716/003-004/010 |
Mavacamten |
Bristol-Myers Squibb Pharma EEIG |
— |
| Cancidas 50 mg powder for concentrate for solution for infusion EU/1/01/196/001 |
Caspofungin |
Merck Sharp & Dohme BV |
— |
| Cancidas 70 mg powder for concentrate for solution for infusion EU/1/01/196/003 |
Caspofungin |
Merck Sharp & Dohme BV |
— |
| Capasal Therapeutic Shampoo PA23128/008/001 |
Salicylic acid, Coconut oil, Coal tar |
Dermal Laboratories (Ireland) Limited |
Marketed |
| Capecitabine Accord 150 mg film-coated tablets EU/1/12/762/001-006 |
Capecitabine |
Accord Healthcare S.L.U. |
— |
| Capecitabine Accord 300 mg film-coated tablets EU/1/12/762/007-012 |
Capecitabine |
Accord Healthcare S.L.U. |
— |
| Capecitabine Accord 500 mg film-coated tablets EU/1/12/762/013-018 |
Capecitabine |
Accord Healthcare S.L.U. |
— |
| Capecitabine medac 150 mg film-coated tablets EU/1/12/802/001-014 |
Capecitabine |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Capecitabine medac 500 mg film-coated tablets EU/1/12/802/029-042 |
Capecitabine |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Capecitabine Teva 150 mg film-coated tablets EU/1/12/761/001 |
Capecitabine |
Teva B.V. |
— |
| Capecitabine Teva 500 mg film-coated tablets EU/1/12/761/002 |
Capecitabine |
Teva B.V. |
— |
| Caprelsa 100 mg film-coated tablets EU/1/11/749/001 |
Vandetanib |
Esteve Pharmaceuticals S.A. |
— |
| Caprelsa 300 mg film-coated tablets EU/1/11/749/002 |
Vandetanib |
Esteve Pharmaceuticals S.A. |
— |
| CAPVAXIVE solution for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (21-valent) EU/1/25/1913/001-006 |
Pneumococcal Polysaccharide Serotype 3 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 6A Conjugated to CRM197, Pneumococcal polysaccharide serotype 7F conjugated to CRM197, Pneumococcal polysaccharide serotype 8 conjugated to CRM197, Pneumococcal polysaccharide serotype 9N conjugated to CRM197 |
Merck Sharp & Dohme BV, |
— |